Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04932577 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Faecal Microbiota Transplantation for Liver Cirrhosis

Study acronym: CHiFT
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 24, 2025 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints revised (16)v6
  2. Minor Secondary endpoints: 6 to 16
    • Collaborators revised (7)
    • Eligibility criteria shortened, about 2 words
    v5
  3. Notable Primary endpoints: 2 to 1v4 Show 4 more changesShow less
    • Secondary endpoints: 3 to 6
    • Study description shortened, about 9 words
    • Collaborators: 5 to 7
    • Eligibility criteria expanded, about 2 words
  4. Minor Eligibility criteria shortened, about 2 wordsv3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Interventions: Faecal microbiota trnasplantation (Biological), Placebo (Biological) to Faecal microbiota transplantation (Biological), Placebo (Biological)
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose is to investigate the effect of faecal microbiota transplantation (FMT) on complications, progression, and mortality of patients with liver cirrhosis. Further, the investigators want to examine the impact of FMT on the gut microbiota, gut barrier function, systemic inflammation, and immune function.
Trial Details
NCT Number NCT04932577
Lead Sponsor University of Aarhus
Collaborators: Aarhus University Hospital, Aalborg University Hospital, Odense University Hospital, Hvidovre University Hospital, Aalborg University, Esbjerg Hospital - University Hospital of Southern Denmark, Sjælland University Hospital
Conditions
(from sponsor)
Liver Cirrhosis
Related terms Ascites, Gastrointestinal Hemorrhage, Hepatic Encephalopathy, Hepatitis, Alcoholic, Hepatorenal Syndrome, Liver Cirrhosis
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov